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T
hrombus aspiration during primary percutaneous coronary intervention (pPCI) has been used to improve myocardial perfusion through a re du ction of the thrombotic burden eventually resul ting with better clinical outcomes. 1, 2 After the initial enthusiasm derived from the mortality reduction shown in early randomized and observational studies, [3] [4] [5] [6] [7] disa ppointing results have been yielded in more recent larger scale trials testing the routine use of thrombus aspiration in pPCI. [8] [9] [10] [11] [12] As a consequence, this technique has lost its initial appeal and currently is often neglected or even considered as a useless by the interventional cardiologists. The recent meta-analysis by Jolly et al. 13 conducted in more than 18,000 patients once again re in forces the evidence that overall there is no benefit in the routine use of thrombus aspiration during pPCI. However, it has the merit to shed light on the residual potential of this technique, which has pro bably been dismissed too quickly. First, there were no significant differences in the occurrence of cardio va scular events up to 1-year post-pPCI between patients treated conventio nally versus those treated with routine adjunctive thrombus aspiration. Of interest, in the sub group of patients with large angiographic thrombus burden (i.e., TIMI thrombus grade ≥3), thrombus aspira tion was associated with a significant reduction in cardiovascular death [2.5 % vs. 3.1 %; hazard ratio 0.80, 95 % confidence interval (CI), 0.65-0.98, P=0.03]. This meta-analysis in fact assessed data from the three lar gest randomized trials on this topic, namely Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS), 4, 5 Throm bus Aspiration in ST elevation Myocardial Infarction in Scandinavia (TASTE) 8, 9 and Introduction. thrombus aspiration is not recommended as a routine procedure considering the results of large randomised trials. It is necessary to define new indications for thrombus aspiration in myocardial infarction and to conduct appropriate trials. The aim of this paper was to report a patient with succesfful aspiration of large thrombus mass from right coronary artery made after primary balloon angioplasty, and to consider which patients could benefit with this procedure. Case report. a male, 80 years old, has been admitted to a catheterisation laboratory with clinical, biochemical and electrocardiographic signes of acute myocardial infarction with ST segment elevation (STEMI) of inferoposterolateral localisation along with sinus bradycardia and profound arterial hypotension, which all are characteristic for inferior myocardial wall infarction with right ventricular involvement. Two hours after pain onset the patient was admitted to hospital in Bjeljina and sent to catheterisation laborathory straight after. All branchies of left coronary artery were well visualized and without significant stenosis. Right coronary artery was occluded in proximal segment. Predilatation was performed with SC Sprinter legend 2,0x20mm balloon. After predilatation thrombus burden is still large, blood flow was slow with significante residual stenosis. Than, BMS Pro-kinetick energy 3,5x20mm stent was implanted. After stent implantation thrombus burden existed and there was no flow in PLV branch. Thrombus mass was 2 cm long and succesffully aspirated with Export aspiration catheter. Control coronarography showed no residual stenosis and normal blood flow was restored through branches of right coronary artery. Thrombectomy with PCI versus PCI Alone in Patients with STEMI (TOTAL.) 11, 12 While in TAPAS and TOTAL patients were randomized to thrombus aspiration or conventional PCI prior to coro na ry angiography, in TASTE the randomization was per formed after angiography, potentially introducing hete ro geneity in coronary anatomy between the studies. Moreover, thrombus grade was evaluated before wire crossing in TAPAS and TOTAL and after wiring in TASTE. This explains the 74 % rate of patients with thrombus grade 4 or 5 in TOTAL trial, whereas this rate was only 32 % in TASTE. Other differences might concern the data collection (e.g., cerebrovascular accidents were not recorded in TAPAS, and no distinction reported between stroke or TIA in TASTE) and adjudication of clinical end points (independent adjudication in TAPAS and TASTE, monitoring as part of an institutional registry in TASTE). In addition, some differences between the two pooled groups of patients are worth mentioning. First, patients treated with thrombus aspiration showed a longer interval from symptom onset to hospital arrival (190 vs. 185.5 min; P=0.025). While this difference might seem to be trivial, on a larger scale pain-to-needle time is still considered as one of the major determinants of progno sis in STEMI patients. 14 Furthermore, in the thrombus aspiration group a higher frequency of direct stenting (39.5 % vs. 21.1 %, P<0.001) and lower use of glycoprotein IIb/IIIa inhibitors (32.3 % vs. 35.1 %, P<0.001) was recor ded. Thrombus aspiration has been consistently shown to affect procedural strategies in terms of balloon dilatation and stent selection. 4, 6, 8, 15, 16 In particular, it is associated with higher rate of direct stenting, lower rate of post-dilatation, with the implantation of less stents but of larger size as compared with conventional PCI 15, 16 . Whether these technical differences in PCI might have a substantial impact on clinical outcome is still controversial 17, 18 . As to the use of glycoprotein IIb/IIIa, previous evidence suggested that thrombus aspiration is of parti cular benefit in patients treated with glycoprotein IIb/IIIa inhibitors. 19 Such synergistic effect was also confirmed by Pyxaras et al, 20 where the com bination of manual throm bus aspiration with intra ve nous abciximab resulted into a significantly lower in ci dence of adverse cardiovascular events at 1 year compared with the single strategies. In a small randomized study, intracoronary applied tirofiban combined with thrombus aspiration in STEMI patients undergoing pPCI, was associated with improved angiographic and clinical outcomes compared with thrombus aspiration alone or conventional PCI. 21 Similar evidence derives from the In tracoronary Abciximab Infusion and Aspiration Thromb ectomy in Patients Undergoing Percutaneous Coronary Intervention for Anterior ST Segment Elevation Myo cardial Infarction (INFUSE-AMI) trial 22 that showed in a post hoc analysis how median infarct size was lowest in the intracoronary abciximab plus aspiration group.The clinical benefit shown with thrombus aspiration in terms of decreased cardiovascular death in the subgroup of patients with large angiographic thrombus burden was partly offset by an increased rate of stroke or transient ischemic attack (TIA) (0.9% vs. 0.5 %; odds ratio 1.56, 95 % CI, 1.02-2.42; P=0.04). The latter could be attributed to technical issues both operator-and device-related. These include catheter-induced embolization of the thrombus into the systemic vasculature, aggressive guiding catheter manipulation required to advance the aspiration catheter and displacing aortic atheroma, and longer procedure time resulting from the aspiration procedure. 23 The risk of systemic embolization can be reduced with improved technique. For instance, a thrombus that cannot be fully aspirated is at risk of fracturing and shedding fragments or entering still intact into the systemic vasculature, particularly if suction is not maintained in the aspiration catheter, and the guiding catheter is not engaged in the artery as the aspiration catheter is withdrawn. 24 Interestingly, all three trials included in the meta-analysis only evaluated manual thrombus aspiration. While more complex (i.e., mechanical) devices might be more effective in extracting atherothrombotic particles from the coronary arteries, they are bulkier and require selected coronary anatomies. No consistent clinical benefit has been shown with these devices over PCI alone, 19 however, potential benefits from these appa rently more effective thrombectomy devices need to be tested in adequately powered ad hoc prospective studies.
Case presentation
A patient, male, 80 years old, has been admitted to a laboratory for a catheterization with clinical, biochemical and ECG signs of an acute myocardial infarction without ST elevation of an inferoposterolateral region, 2 hours after the occurrence of pain with clinical signs and symptoms of heart failure. TA: 80/60mmHg, Killip IV. Non smokers, does not consume alcohol and without a disease of significance for heredity and chronicity.
Coronary angiography: LM proper deviate, direction, lumen without stenosis, is divided into LAD and LCx. LAD proper deviate, direction, lumen without stenosis. LCx proper deviate, direction, lumen without stenosis. RCA: proper deviate, proximally occluded 100% (figure 1).
pPCI RCA: we set SH guiding catheter in the RCA ostium. BMW coronary wire was placed in the periphery of the RCA. We performed predilatation occluded seg ment with balloon SC Sprinter legend 2,0x20 mm insu fflation to 16atm, followed by establishing flow through the artery (figure 2). Implanted stents medial BMS Pro-kinetick energy 3,5x20mm insufflation to 16atm. ( figure 3 ). On the control coronarography, a thrombus is seen in the direction of the PL branch which is successfully aspirated by the Export catheter (figure 5). Thereafter flow in all branches of TIMI III, without residual stenosis and without dissection (figure 4).
Discussion
The patient was admitted to the catheterization laboratory with clinical, biochemical and electrocardiographic signs of acute myocardial infarction with ST elevation of the inferoposterolateral region with sinus bradycardia, 2 hours after the onset of pain with clinical signs and symptoms of cardiac failure, TA: 80/60 mmHg, Killip IV. After the described intervention, the patient was hemodynamically stable, compensated with electrocardiographic signs of ischemia in inferior leads of ECG. The aim of the case is to indicate its significance in the primary PCI of acute myocardial infarction with ST elevation. Overall, the lesson derived from the metaanalysis by Jolly et al., and in general from the literature produced over the last 10 years and the case itself, is that performing thrombus aspiration routinely during pPCI does not result into substantial clinical benefit and in some situations, might be potentially harmful. However, thrombus aspiration if carefully performed may still be considered as a valuable technique in selected patients with large angiographic thrombotic burden.
